Literature DB >> 11149413

Spanish family study on hereditary breast and/or ovarian cancer: analysis of the BRCA1 gene.

M de la Hoya, P Pérez-Segura, N Van Orsouw, E Díaz-Rubio, T Caldés.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11149413     DOI： 10.1002/1097-0215(20010101)91:1<137::aid-ijc1020>3.0.co;2-r

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  4 in total

1.  Lack of germ-line mutations at the specific BRCA1-IRIS coding sequence in 114 Spanish high-risk breast/ovarian families.

Authors:  Miguel de la Hoya; Juan Manuel Fernández; Ana Sánchez de Abajo; Alicia Tosar; Eduardo Díaz-Rubio; Trinidad Caldés
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers.

Authors:  Ana Custodio; Antonio J López-Farré; José J Zamorano-León; Petra J Mateos-Cáceres; Carlos Macaya; Trinidad Caldés; Miguel de la Hoya; Elena Olivera; Javier Puente; Eduardo Díaz-Rubio; Pedro Pérez-Segura
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-07       Impact factor: 4.553

3.  The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families.

Authors:  Ana Sánchez de Abajo; Miguel de la Hoya; Javier Godino; Vicente Furió; Alicia Tosar; Pedro Pérez-Segura; Eduardo Díaz-Rubio; Trinidad Caldés
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Non-BRCA1/2 Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer.

Authors:  Christina Adaniel; Francisca Salinas; Juan Manuel Donaire; Maria Eugenia Bravo; Octavio Peralta; Hernando Paredes; Nuvia Aliaga; Antonio Sola; Paulina Neira; Carolina Behnke; Tulio Rodriguez; Soledad Torres; Francisco Lopez; Claudia Hurtado
Journal:  J Glob Oncol       Date:  2019-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.